| Name |
transforming growth factor alpha |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
| Structure |
|
|
| GO Annotations |
Cellular Component |
|
|
| Molecular Function |
|
|
| Biological Process |
|
|
| Pathways |
|
|
| Diseases |
|
None
|
| GWAS |
- Acne (severe) ( 24927181
)
- Cough in response to angiotensin-converting enzyme inhibitor drugs ( 28084903
)
- Hair shape ( 29220522
)
- Hand grip strength ( 29691431
29313844
)
- Heel bone mineral density ( 30598549
)
- Hip minimal joint space width ( 27701424
)
- Longevity ( 20834067
)
- Low hand grip strength (60 years and older) (EWGSOP) ( 33510174
)
- Low hand grip strength (60 years and older) (FNIH) ( 33510174
)
- Neutrophil count ( 21507922
)
- Obesity-related traits ( 23251661
)
- Osteoarthritis ( 30664745
)
- Pulse pressure in young-onset hypertension ( 24892410
)
- Response to citalopram or escitalopram in depression ( 27622933
)
- Response to esketamine in treatment resistant depression ( 32724131
)
- Severe progression in rheumatoid arthritis ( 29065906
)
- Superior frontal gyrus grey matter volume ( 25335168
)
|
- Acute lymphoblastic leukemia (childhood) ( 23007406
)
- Adult body size ( 32376654
)
- Adverse response to drug ( 30420678
)
- Airway wall thickness ( 25517131
)
- Bitter beverage consumption ( 31046077
)
- Body mass index ( 25673413
28892062
)
- Body size at age 10 ( 32376654
)
- Bronchopulmonary dysplasia ( 23897914
)
- Chronotype ( 30696823
)
- Computer vision syndrome ( 33941792
)
- Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes ( 29221444
)
- Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes ( 29221444
)
- General risk tolerance (MTAG) ( 30643258
)
- Hippocampal atrophy ( 19668339
)
- Itch intensity from mosquito bite adjusted by bite size ( 28199695
)
- LDL cholesterol levels x short total sleep time interaction (1df test) ( 31719535
)
- LDL cholesterol levels x short total sleep time interaction (2df test) ( 31719535
)
- Lead levels in blood ( 25820613
)
- Low density lipoprotein cholesterol levels ( 33339817
)
- Mammographic density (dense area) ( 25342443
)
- Memory dysfunction in frontotemporal lobe dementia ( 29724592
)
- Metabolite levels ( 23823483
)
- Nicotine dependence ( 33144568
)
- Night sleep phenotypes ( 27126917
)
- Obesity-related traits ( 23251661
)
- Pursuit maintenance gain ( 29064472
)
- Refractive error ( 32231278
)
- Response to anti-depressant treatment in major depressive disorder ( 22041458
)
- Response to lamotrigine and valproic acid in genetic generalized epilepsy ( 32308125
)
- Schizophrenia ( 30285260
28991256
)
- Serum folate levels ( 29953918
)
- Total cholesterol levels ( 33339817
)
- Visceral fat ( 30942860
)
|
| Interacting Genes |
17 interacting genes:
ADAM10
ADAM17
EGFR
ELANE
ERBB2
ERBB4
GORASP1
GORASP2
LEPROTL1
MAGI2
MAGI3
NKD2
RHBDD1
RHBDF1
SDCBP
SGTA
SNTA1
|
30 interacting genes:
ACVR2A
ADGRB1
ADRB1
ARRDC3
ATN1
CRHR1
CTNNB1
CTNND2
DLGAP1
DLGAP2
DLGAP3
DLL1
DSCAM
DSCAML1
DYRK3
GRID2
LCOR
MORN4
PDZD11
PLEKHF2
PLXNB3
PRRG4
PTEN
RAPGEF2
RIPK4
RPS6KA1
SMAD3
SNRPB
TGFA
VANGL2
|
| Entrez ID |
7039 |
9863 |
| HPRD ID |
07522
|
16212
|
| Ensembl ID |
ENSG00000163235
|
ENSG00000187391
|
| Uniprot IDs |
E7EPT6
F8VNR3
P01135
|
B7Z4H4
Q86UL8
|
| PDB IDs |
1GK5
1MOX
1YUF
1YUG
2TGF
3E50
3TGF
4TGF
5KN5
7SZ5
7SZ7
|
1UEP
1UEQ
1UEW
1UJV
1WFV
|
| GO Terms Enriched among Interactors |
|
|